Showing results (1891-1900 of 1,911) with videos related to
Sort By:
Pageof 192
Brain : a Journal of Neurology|February 24, 2023
GGC repeat expansion in NOTCH2NLC induces dysfunction in ribosome biogenesis and translationYu Fan, Meng-Jie Li, Jing Yang, et al.Bone Marrow Transplantation|April 2, 2024
Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experienceRui Ma, Dan-Ping Zhu, Xiao-Hui Zhang, et al.Nature Medicine|July 24, 2023
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trialSi-Yang Maggie Liu, Hai-Yan Tu, Xue-Wu Wei, et al.Paediatric Anaesthesia|April 10, 2026
Chinese Society of Pediatric Anesthesiology Guideline for Pediatric Sedation (2025)Xingrong Song, Dongxu Lei, Yu Cui, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 6, 2022
Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b StudyYuankai Shi, Baolan Li, Lin Wu, et al.The Lancet. Oncology|June 16, 2025
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): 4-year outcomes from a double-blind, randomised, phase 3 trialCaicun Zhou, Ziping Wang, Meili Sun, et al.Cancer Communications (London, England)|April 2, 2026
Rezivertinib in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Central Nervous System Metastasis: Central Nervous System Efficacy from the Phase III REZOR StudySheng Yang, Yanqiu Zhao, Meili Sun, et al.JAMA|May 26, 2021
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical TrialNawal Al Kaabi, Yuntao Zhang, Shengli Xia, et al.The Lancet. Respiratory Medicine|May 27, 2023
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 studyShun Lu, Jianying Zhou, Hong Jian, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 24, 2026
Deulorlatinib (TGRX-326) in ALK gene fusion positive non-small cell lung cancer after failure of second-generation inhibitors (DRAGON): a single-arm, multicenter, phase 2 trialJie Huang, Gang Chen, Zhehai Wang, et al.Pageof 192